Arsenic is a naturally occurring and highly potent metalloid known to elicit serious public health concerns. Today, approximately 200 million people around the globe are exposed to arsenic-contaminated drinking water at levels greater than the World Health Organization's recommended limit of 10 parts per billion. As a class I human carcinogen, arsenic exposure is known to elicit various cancers, including lung, skin, liver, and kidney. Current evidence suggests that arsenic is capable of inducing both genotoxic and cytotoxic injury, as well as activating epigenetic pathways to induce carcinogenesis. Our study identifies a novel pathway that is implicated in arsenicinduced carcinogenesis. Arsenic down-regulated miRNA-31 and the release of this inhibition caused overexpression of special AT-rich sequence-binding protein 2 (SATB2). Arsenic is known to disrupt miRNA expression, and here we report for the first time that arsenic is capable of inhibiting miR-31 expression. As a direct downstream target of miR-31, SATB2 is a prominent transcription factor, and nuclear matrix binding protein implicated in many types of human diseases including lung cancer. Results from this study show that arsenic induces the overexpressing SATB2 by inhibiting miR-31 expression, which blocks the translation of SATB2 mRNA, since levels of SATB2 mRNA remain the same but protein levels decrease. Overexpression of SATB2 induces malignant transformation of human bronchial epithelial (BEAS-2B) cells indicating the importance of the expression of miR-31 in preventing carcinogenesis by suppressing SATB2 protein levels.
carcinogen, the World Health Organization's maximum recommended limit for arsenic in drinking water is set at 10 parts per billion (ppb). However, alarmingly high levels of arsenic that often exceed these levels in drinking water have been detected in various parts of the world including, Bangladesh, Pakistan, the French Mediterranean coast, China, Mexico, United States, etc. 1 Even though most people are exposed via contaminated drinking water, inhalation of toxic dusts in occupational settings such as nickelrefineries, and ingestion of food containing arsenic are also prominent exposure routes. [2] [3] [4] Today, approximately 200 million people around the globe are exposed to potentially toxic levels of arsenic. Arsenic is an IARC Class I human carcinogen, chronic arsenic exposure has been implicated in serious human cancers including cancers of the lung, skin, kidney, urinary bladder, and liver. 5 Extended research efforts have been carried out to elucidate the mechanisms responsible for arsenic-induced carcinogenesis. Current evidence suggests that arsenic is capable of causing cancer through both genotoxic and cytotoxic, as well as epigenetic pathways. 6 Here we report that arsenic induces malignant transformation in human bronchial epithelial (BEAS-2B) cells by inhibiting miRNA-31 expression, which subsequently leads to the overexpression of special AT-rich sequence-binding protein 2 (SATB2) to levels that can induce malignant transformation of BEAS2B cells.
SATB2 resides in the gene poor region, 2q32-q33, and was first isolated from human fetal brain cDNA library as a part of the Human Unidentified Gene-Encoded (HUGE) protein database project. 7, 8 SATB2 is a transcription factor critically important for the biological development of various tissues such as osteoblast, as well as differentiation of neurons, and stem cells. [8] [9] [10] [11] [12] [13] [14] [15] In addition, SATB2 is also considered a nuclear matrix attachment region (MAR) binding protein. 8 Nuclear matrix attachment regions contain numerous AT sequences that can non-specifically bind to the minor grove of the target DNA. Through its structural recognition, MARs can regulate gene expression, and higher-order chromatin states by having multiple binding sites that target more than one gene. [16] [17] [18] [19] [20] As a prominent MAR-binding protein, the ability for SATB2 to bind to AT-rich DNA sequences allows for its interaction with specific metastasis-associated proteins as well as histone acetylases and deacetylases, which can in turn influence epigenetic signals and overall genome stability. 21, 22 The levels of SATB2 expression vary by tissue type. 
| Western blotting
Cells were lysed with boiling buffer (1% SDS, 10 mM Tris (pH 7.4), 1 mM sodium orthovanadate) and 50 µg of whole cell lysate were separated by 12% SDS-PAGE and transferred to a PVDF membrane.
After blocking in 5% skim milk in TBST for 1 h at room temperature, the membrane was incubated with SATB2 mouse monoclonal antibody (Abcam, Cambridge, MA., ab51502, 1:100) overnight at 4°C, and then probed with HRP labeled goat anti mouse secondary antibody (1:2000) for 1 h at room temperature before the visualization by the chemiluminescence. Quantification of immunodetected proteins was performed using Image J software.
| Quantitative real-time PCR
Total RNA was extracted using TRIzol (Invitrogen) and subsequently synthesized into single-stranded cDNA using ProtoScript® II First Eclipse TS100 microscope (Nikon Instruments Inc., Tempe, AZ).
| Transwell cell invasion assay

| Statistical analysis
Image J image processing software (National Institute of Health) was used to quantify Western blotting gel intensities. All statistical significance was calculated and assessed using unpaired, two tailed t-test, where *indicates P < 0.05 and **indicates P < 0.01. 52 here we report that 6 weeks of 2 μM arsenic exposure was sufficient to induce anchorage-independent growth in BEAS-2B cells ( Figure 1A ). Of note, two micromolar of arsenic is equivalent to 150 ppb, which are similar to levels found in the environment. 49, 53 As shown in Figure 1B , arsenic-transformed BEAS-2B cells showed significantly more colony growth in soft agar compared to the control group. In addition to anchorage-independent growth, we also examined the rate of cell migration using As-transformed cells selected from soft agar colonies. Scratch tests were implemented to compare the difference in migration abilities between As-transformed and normal BEAS-2B cells.
As expected, after the first 24 h period, As-transformed cells exhibited significantly faster wound-healing capability than the control cells ( Figures 1C and 1D ). In light of previous studies illustrating up regulated SATB2 expression following exposure to heavy metals, 25, 26 the mRNA and protein levels of SATB2 were measured following various doses and time periods of arsenic treatment. Using quantitative real-time PCR (qPCR), significant increases in SATB2 mRNA levels were detected in arsenic-transformed cells ( Figure 1E ). In addition, arsenic-transformed clones also displayed markedly increased SATB2 protein levels compared with control cells ( Figure 1F) . Furthermore, as shown in Figure 1G , Western blotting analysis of BEAS-2B cells exposed to 1.25, shRNA, and cells were tested for growth in soft agar. As indicated by the number of colonies in Figures 2C and 2D , knocking down SATB2 
| SATB2 knockdown prevents as-induced transformation in BEAS-2B cells
In line with the finding that SATB2 reduction eliminated the transformation properties of arsenic-transformed cells, we investigated whether knocking down of SATB2 in normal BEAS-2B cells prior to arsenic exposure would prevent arsenic-induced cell transformation. Of note, under normal conditions, SATB2 is only weakly expressed in the lung, but not detectable in BEAS-2B cells. 26, 55 We knocked down SATB2 in BEAS-2B cells that do not express this gene, using stable shRNA transfection to prevent its expected increase in expression after exposure to arsenic. SATB2 was stably knocked down in BEAS-2B cells using shRNA (BEAS-2B/SATB2 shRNA) and cells were treated with 2 μM of arsenic for six consecutive weeks. As illustrated in Figure 3A , after 6 weeks of arsenic exposure, the empty Collectively, our data show that arsenic-induced anchorage-independent growth and cell migration were attenuated when SATB2 expression was lowered, which further suggest that SATB2 was essential for the hallmarks of arsenic-induced cell transformation. 3.5 | Overexpression of miR-31 rescues as-induced anchorage-independent growth, cell migration, and invasion
MiR-31 was overexpressed in arsenic-transformed cells by stable transfection ( Figure 5A ). Since miR-31 is a negative regulator of SATB2, overexpression of miR-31 should presumably decrease SATB2 expression.
As indicated in Figure 5B , overexpressing of miR-31 in arsenic-transformed cells caused a reduction in SATB2 protein level as compared with empty vector. However, as shown in Figure 5C , SATB2 mRNA levels remain unchanged. Similar findings were reported in osteogenic differentiation of bone mesenchymal stem cells. 48 These results suggest that miR-31 affected SATB2 translation without changing the levels of its mRNA ( Figure 5D ).
After verifying miR-31 overexpression in arsenic-transformed cells, the level of cell transformation was assessed by growth in soft agar ( Figure 5E ). There was significantly less colony growth in arsenic-transformed cells overexpressing miR-31 compared with empty vector cells. This result suggests that miR-31 may play an important role in arsenic-induced anchorage- This is the first study to describe a role of miR-31 and SATB2 in arsenicinduced cell transformation. As a potent class I human carcinogen, mounting scientific research efforts have been conducted to uncover the mechanisms, and pathways by which arsenic exerts its carcinogenicity. In addition to the commonly studied epigenetic alterations such as DNA methylation and histone post-translational modifications, miRNA-mediated silencing also plays an important role in arsenic-induced carcinogenesis. 44 Defects in the proper regulation of epigenetic marks can lead to inappropriate activation or suppression of critical oncogenes or tumor suppressor genes, which can lead to cancer development. 59, 60 The expression of SATB2 is often found disrupted in various types of cancers including lung, breast, colon, and ovarian cancers. However, the precise role of SATB2 in carcinogenesis remains unclear due to its varied apparent functions in different types of tissues from which cancers can arise. For example, evidence suggests that SATB2 is overexpressed and acts as an oncogene in lung, colorectal, Merkel cell, and hepatocellular carcinoma. 23, 31, 35 In addition, elevated mRNA levels of SATB2 is linked to poor breast cancer grade. 20, 35 On the other hand, SATB2 has also been shown to function as a tumor suppressor gene in lung, gastric, as well as colorectal cancers. [26] [27] [28] [29] [30] [31] [32] [33] [34] The opposite roles of SATB2 are cell-specific, and further evidence is still needed to better understand its role in cancer development.
In the past two decades, interest in non-coding RNAs has increased able to show that some miRNAs may be capable reducing transcript levels, it remains unknown whether miRNA-induced gene expression is directly through mRNA degradation or if the phenomenon is due to off-target effects of miRNA-like activity. 65 In addition, online database searches using miRSys and miRMap as well as gene list analyses using Toppgene, suggested that both miR-31 and SATB2 were directly involved in cell migration, motility, and gene expression regulation, all of which may be point to ways that these processes induce cell transformation.
Arsenic exposure reduces miR-31 expression, which slows the degradation of SATB2 mRNA and expression. As a possible tumor promoter, down regulation of miR-31 and overexpression of SATB2
were directly linked to the hallmarks of cancer including anchorage-
FIGURE 6
Model demonstrating the effect of acute and chronic arsenic exposure on SATB2 and miR-31 independent growth, cell invasion, and accelerated cell migration in arsenictransformed cells. However, further research is still needed to understand how arsenic induces the down-regulation of miR-31. Some evidence suggests that expression of Runt-related transcription factor 2 (RUNX2) was also regulated by arsenic, and that this gene participates in a regulatory loop with SATB2 and miR-31 to induce osteogenic differentiation, 48, 66 but no studies are currently available in human bronchial epithelial cell models.
Given that SATB2 overexpression is induced by other heavy metals such as nickel and chromium, which are also carcinogenic, the pathways reported here may be a common phenomenon for heavy metal-induced lung carcinogenesis.
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